It is reported that baseline AFP level affected the prognosis and treatment outcomes10 of patients treated with systemic chemotherapy for HCC.19 In addition, the number of patients with extrahepatic metastasis, which predicts poor response,10 was lower than that of the REFLECT trial. This evidence concerns the gene AFP and hepatocellular carcinoma.